NNC0165-1875

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NNC0165-1875, covering 2026-01-08 to 2026-01-08. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With Obesity [Phase 2]

See pricing